Quirino v. Secretary of Health and Human Services

CourtUnited States Court of Federal Claims
DecidedAugust 25, 2020
Docket17-989
StatusUnpublished

This text of Quirino v. Secretary of Health and Human Services (Quirino v. Secretary of Health and Human Services) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Quirino v. Secretary of Health and Human Services, (uscfc 2020).

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 17-989V Filed: July 31, 2020 UNPUBLISHED

Special Master Horner JASON QUIRINO,

Petitioner, Interim Attorneys’ Fees and v. Costs Decision SECRETARY OF HEALTH AND HUMAN SERVICES,

Respondent.

Andrew Donald Downing, Van Cott & Talamante, PLLC, Phoenix, AZ, for petitioner. Darryl R. Wishard, U.S. Department of Justice, Washington, DC, for respondent.

DECISION AWARDING INTERIM ATTORNEYS’ FEES AND COSTS1

On May 12, 2020, petitioner moved for an award of interim attorneys’ fees and costs in the amount of $39,267.47 for his current counsel and $17,933.53 for his prior counsel. (ECF No. 60.) In response, respondent deferred to the special master regarding both the amount and appropriateness of an award of interim attorneys’ fees and costs. (ECF No. 61.) However, respondent did note that “respondent is satisfied the statutory requirements and other legal requirements for an award of attorneys’ fees and costs are met.” (Id. at 2.) For the reasons discussed below, I award petitioner interim attorneys’ fees and costs in reduced amount of $33,623.97 for current counsel and $17,408.53 for prior counsel.

I. Procedural History

On July 21, 2017, petitioner filed this claim, under the National Childhood Vaccine Injury Act, 42 U.S.C. § 300aa-10-34 (2012), alleging that as a result of his July

1 Because this decision contains a reasoned explanation for the special master’s action in this case, it will be posted on the United States Court of Federal Claims’ website in accordance with the E-Government Act of 2002. See 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). This means the decision will be available to anyone with access to the Internet. In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to redact medical or other information the disclosure of which would constitute an unwarranted invasion of privacy. If the special master, upon review, agrees that the identified material fits within this definition, it will be redacted from public access. 28, 2014 Hepatitis B (“Hep B”) and Tetanus-Diphtheria-acellular-Pertussis (“Tdap”) vaccination he suffered a rheumatologic injury. (ECF No. 1.) Petitioner filed an amended petition on December 19, 2019, alleging that his July 28, 2014 vaccinations actually caused him to suffer an atypical form of Guillain-Barre syndrome (“GBS”), manifesting as an isolated small fiber neuropathy. (ECF No 53.)

This case was originally assigned to Special Master Moran and subsequently reassigned to Special Master Sanders. (ECF Nos. 4, 20.) On February 27, 2018, respondent filed his Rule 4(c) report, recommending against compensation. (ECF No. 27.) On July 25, 2018, Andrew Donald Downing substituted in as the attorney on record in place of Ronald Craig Homer. (ECF No. 38.)

Subsequently, petitioner filed an expert report from Dr. Laura S. Boylan to support his claim and, in response, respondent filed an expert report from Dr. Jeffrey M. Gelfand. (ECF Nos. 41, 46.) This case was then reassigned to my docket on August 29, 2019. (ECF No. 49.) Following a status conference held on September 23, 2020, petitioner filed an amended petition and supplemental report from Dr. Boylan. (ECF Nos. 53, 57.) Respondent also filed a supplemental report from Dr. Gelfand. (ECF No. 62.) On July 20, 2020, per petitioner’s request, this case has been queued for the scheduling of an entitlement hearing. (ECF No. 64.)

Petitioner filed the instant motion for interim attorneys’ fees and costs on May 12, 2020, respondent filed his response on May 13, 2020, and petitioner did not file a reply. (ECF Nos. 60-61.) Accordingly, petitioner’s motion for interim attorneys’ fees and costs is now ripe for resolution.

II. An Award of Interim Attorneys’ Fees and Costs is Appropriate

Section 15(e)(1) of the Vaccine Act allows for the special master to award “reasonable attorneys' fees, and other costs.” § 300aa–15(e)(1)(A)–(B). Petitioners are entitled to an award of reasonable attorneys' fees and costs if they are entitled to compensation under the Vaccine Act, or, even if they are unsuccessful, if the special master finds that the petition was filed in good faith and with a reasonable basis. Avera v. Sec'y of Health & Human Servs., 515 F.3d 1343, 1352 (Fed. Cir. 2008). In his response, respondent indicated that the statutory requirements were met in this case. (ECF No. 61, p. 2.) I agree.

Additionally, the Federal Circuit has concluded that interim fee awards are permissible and appropriate under the Vaccine Act. Shaw v. Sec’y of Health & Human Servs., 609 F.3d 1372 (Fed. Cir. 2010); Avera, 515 F.3d at 1352. In Avera, the Federal Circuit stated, “[i]nterim fees are particularly appropriate in cases where proceedings are protracted and costly experts must be retained.” Id. In denying an interim fee award, the Avera court reasoned, “The amount of fees here was not substantial; appellants had not employed any experts; and there was only a short delay in the award pending the appeal.” Id. In Shaw, the Federal Circuit clarified that “where the claimant establishes that the cost of litigation has imposed an undue hardship and there exists a

2 good faith basis for the claim, it is proper for the special master to award interim attorneys’ fees.” 609 F.3d at 1375.

Here, petitioner’s request for interim attorneys’ fees and costs is made after more than two years of litigation within the entitlement phase of this case and after petitioner incurred costs for providing multiple expert reports to support his claim. Additionally, this case is awaiting an entitlement hearing, and thus, the timing of the ultimate resolution of this case remains unknown. Accordingly, I find that petitioner’s request for an award for interim attorneys’ fees and costs is reasonable at this juncture.

III. Reasonableness of the Requested Award

a. Attorneys’ Fees

It is “well within the special master’s discretion” to determine the reasonableness of fees. Saxton v. Sec’y of Health & Human Servs., 3 F.3d 1517, 1521-22 (Fed. Cir. 1993); see also Hines v. Sec’y of Health & Human Servs., 22 Cl. Ct. 750, 753 (1991) (“[T]he reviewing court must grant the special master wide latitude in determining the reasonableness of both attorneys’ fees and costs.”). The Federal Circuit has approved the lodestar approach to determine reasonable attorneys’ fees and costs under the Vaccine Act. Avera, 515 F.3d at 1347. This is a two-step process. Id. at 1347-48. First, a court determines an “initial estimate…by ‘multiplying the number of hours reasonably expended on the litigation times a reasonable hourly rate.’” Id. (quoting Blum v. Stenson, 465 U.S. 886, 888 (1984)). Second the court may make an upward or downward departure from the initial calculation of the fee award based on specific findings. Id. at 1348.

A reasonable hourly rate is “the prevailing market rate defined as the rate prevailing in the community for similar services by lawyers of reasonably comparable skill, experience, and reputation.” Avera, 515 F.3d at 1348 (citation and quotation omitted).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Quirino v. Secretary of Health and Human Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/quirino-v-secretary-of-health-and-human-services-uscfc-2020.